Dual Role of G-runs and hnRNP F in the Regulation of a Mutation-Activated Pseudoexon in the Fibrinogen Gamma-Chain Transcript

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Rimoldi, Valeria ^a   Soldà, Giulia ^a   Asselta, Rosanna ^a   Spena, Silvia ^a   Stuani, Cristiana ^b   Buratti, Emanuele ^b   Duga, Stefano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; FIBRINOGEN; FIBRINOGEN GAMMA CHAIN; GUANINE NUCLEOTIDE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H; MESSENGER RNA; SERINE ARGININE RICH PROTEIN; SERINE ARGININE RICH PROTEIN 40; TRANS ACTING FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA STRUCTURE; EXON; FEMALE; G RUN ELEMENT; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENE STRUCTURE; HUMAN; HUMAN CELL; INTRON; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PSEUDOEXON; TRANS SPLICING; TRANSCRIPTION REGULATION; UPREGULATION;

EXONS; FIBRINOGEN; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HUMANS; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84875340373     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059333     Document Type: Article

References (37)

1. Hertel K, (2008) Combinatorial control of exon recognition. J Biol Chem 283: 1211-1215.
2. Fu X, (2004) Towards a splicing code. Cell 119: 736-738.
3. Wang G, Cooper T, (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8: 749-761.
4. Cartegni L, Chew S, Krainer A, (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285-298.
5. Liu H, Zhang M, Krainer A, (1998) Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev 12: 1998-2012.
6. Jensen C, Oldfield B, Rubio J, (2009) Splicing, cis genetic variation and disease. Biochem Soc Trans 37: 1311-1315.
7. Buratti E, Stuani C, De Prato G, Baralle F, (2007) SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer. Nucleic Acids Res 35: 4359-4368.
8. Caputi M, Zahler A, (2002) SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. EMBO J 21: 845-855.
9. Motta-Mena L, Heyd F, Lynch K, (2010) Context-dependent regulatory mechanism of the splicing factor hnRNP L. Mol Cell. 37: 223-234.
10. López-Bigas N, Audit B, Ouzounis C, Parra G, Guigó R, (2005) Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett 579: 1900-1903.
11. Blencowe B, (2006) Alternative splicing: new insights from global analyses. Cell 126: 37-47.
12. Pagani F, Baralle F, (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5: 389-396.
13. Briese M, Esmaeili B, Sattelle D, (2005) Is spinal muscular atrophy the result of defects in motor neuron processes? Bioessays 27: 946-957.
14. Mordes D, Luo X, Kar A, Kuo D, Xu L, et al. (2006) Pre-mRNA splicing and retinitis pigmentosa. Mol Vis 12: 1259-1271.
15. Grellscheid S, Smith C, (2006) An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon. Mol Cell Biol 26: 2237-2246.
16. Dhir A, Buratti E, (2010) Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies. FEBS J 277: 841-855.
17. Spena S, Asselta R, Platé M, Castaman G, Duga S, et al. (2007) Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia. Br J Haematol 139: 128-132.
18. Garneau D, Revil T, Fisette J, Chabot B, (2005) Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J Biol Chem 280: 22641-22650.
19. Crawford J, Patton J, (2006) Activation of alpha-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F. Mol Cell Biol. 26: 8791-8802.
20. Marcucci R, Baralle FE, Romano M, (2007) Complex splicing control of the human Thrombopoietin gene by intronic G runs. Nucleic Acids Res 35: 132-142.
21. Cartegni L, Wang J, Zhu Z, Zhang M, Krainer A, (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31: 3568-3571.
22. Smith P, Zhang C, Wang J, Chew S, Zhang M, et al. (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15: 2490-2508.
23. Alkan SA, Martincic K, Milcarek C, (2006) The hnRNPs F and H2 bind to similar sequences to influence gene expression. Biochem J 393: 361-371.
24. Sun H, Chasin L, (2000) Multiple splicing defects in an intronic false exon. Mol Cell Biol 20: 6414-6425.
25. Fairbrother W, Chasin L, (2000) Human genomic sequences that inhibit splicing. Mol Cell Biol 20: 6816-6825.
26. Sironi M, Menozzi G, Riva L, Cagliani R, Comi G, et al. (2004) Silencer elements as possible inhibitors of pseudoexon splicing. Nucleic Acids Res 32: 1783-1791.
27. Zhang X, Chasin L, (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 18: 1241-1250.
28. Zhang X, Leslie C, Chasin L, (2005) Dichotomous splicing signals in exon flanks. Genome Res 15: 768-779.
29. Venables J, Koh C, Froehlich U, Lapointe E, Couture S, et al. (2008) Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol Cell Biol 28: 6033-6043.
30. Mauger D, Lin C, Garcia-Blanco M, (2008) hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc. Mol Cell Biol 28: 5403-5419.
31. Wang E, Cambi F, (2009) Heterogeneous nuclear ribonucleoproteins H and F regulate the proteolipid protein/DM20 ratio by recruiting U1 small nuclear ribonucleoprotein through a complex array of G runs. J Biol Chem 284: 11194-11204.
32. Dominski Z, Kole R, (1991) Selection of splice sites in pre-mRNAs with short internal exons. Mol Cell Biol 11: 6075-6083.
33. Wang E, Mueller WF, Hertel KJ, Cambi F, (2011) G Run-mediated recognition of proteolipid protein and DM20 5′ splice sites by U1 small nuclear RNA is regulated by context and proximity to the splice site. J Biol Chem 11 286: 4059-4071.
34. Pagani F, Buratti E, Stuani C, Romano M, Zuccato E, et al. (2000) Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J Biol Chem 275: 21041-21047.
35. Pagani F, Buratti E, Stuani C, Bendix R, Dörk T, et al. (2002) A new type of mutation causes a splicing defect in ATM. Nat Genet 30: 426-429.
36. Sevo M, Buratti E, Venturi V, (2004) Ribosomal protein S1 specifically binds to the 5′ untranslated region of the Pseudomonas aeruginosa stationary-phase sigma factor rpoS mRNA in the logarithmic phase of growth. J Bacteriol 186: 4903-4909.
37. Buratti E, Baralle M, De Conti L, Baralle D, Romano M, et al. (2004) hnRNP H binding at the 5′ splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes. Nucleic Acids Res 32: 4224-4236.